Klinisch-Molekularbiologisches Forschungszentrum

P133-OA: Combined targeting of chemoresistant cancer cells and immune-suppressive CAFs for cancer therapy Jan. 1, 2024 - Sept. 30, 2024 Zeb1-vermittelte Kontrolle des PUFA/MUFA-Verhältnisses in der EMT-assoziierten Ferroptose-Sensitivität Aug. 1, 2021 - July 31, 2024 ZEB1 exprimierende Makrophagen kontrollierne die metastatische Kolonisierung (B01) (SFB/TRR 305 B01) TRR 305: Über die Analyse der metastatischen Koloniebildung zu neuen systemischen Krebstherapien Jan. 1, 2021 - Jan. 1, 2024 D030 (Experim. Medizin II): Functional role of axin anchoring to microtubules in Wnt signaling March 1, 2020 - Feb. 28, 2023 Zusammenspiel des EMT Transkriptionsfaktors ZEB1 mit dem MRN DNA-Reparatur-Komplex - spezifischer Angriffspunkt für die Krebstherapie Dec. 1, 2020 - Nov. 30, 2022 P058 (Exp. Medizin II): Optimisation and characterisation of a Wnt signalling-inhibiting peptide with potential for cancer therapy April 16, 2020 - April 15, 2021 Interaction of the EMT-activator ZEB1 and the Yap/Taz/Hippo-pathway in cancer Feb. 1, 2017 - July 31, 2020 P034 (Biochemie, Mol. Medizin): Myeloid-specific functions of the EMT-inducer ZEB1 in colorectal cancer. Jan. 16, 2019 - Jan. 15, 2020 The role of the EMT-inducer Zeb1 in the invasive tumor stroma during colon cancer progression (FOR 2438) FOR 2438: Cell Plasticity in Colorectal Carcinogenesis Jan. 1, 2016 - Jan. 14, 2020 Role of the EMT activator ZEB1 in pancreatic cancer invasion, dissemination and metastasis Jan. 1, 2016 - March 31, 2019